AIM ImmunoTech Announces Publication of Data from Roswell Park Comprehensive Cancer Center Phase 1 Study Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen in Metastatic Triple-Negative Breast Cancer
November 14, 2023 10:00 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of results from the Phase 1 study at Roswell Park...
Blackford and AIQ Solutions Announce Commercial Partnership to Bring Advanced Clinical Decision Support Tools for Metastatic Cancer to Healthcare Providers
November 14, 2023 09:00 ET
|
Blackford
Blackford and AIQ Solutions Announce Commercial Partnership to Bring Advanced Clinical Decision Support Tools for Metastatic Cancer to Healthcare Providers
Q-Centrix Launches the Research Network to Expand the Impact of Clinical Data by Connecting Hospitals and Life Sciences Organizations
November 14, 2023 08:00 ET
|
Q-Centrix
The platform builds upon Q-Centrix’s ethos that data management is critical to expanding clinical research and trials
Occlusion Devices Market Size Worth USD 5,588.20 Million by 2032 | Emergen Research
November 13, 2023 12:30 ET
|
Emergen Research
Vancouver, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The global occlusion devices market is projected to be worth USD 5,588.20 Million by 2032, according to a current analysis by Emergen Research. The...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
November 13, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
November 13, 2023 07:30 ET
|
POINT Biopharma
INDIANAPOLIS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to...
Glycomics Market to be Worth USD 3.1 billion by 2031 Globally, at a CAGR of 11.2 % | TMR Report
November 13, 2023 05:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global glycomics market is projected to flourish at a CAGR of 11.2% from 2023 to 2031....
Active Pharmaceutical Ingredients (API) Market to Hit USD 331.3 billion by 2031 | Says Transparency Market Research Inc.
November 13, 2023 02:24 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global active pharmaceutical ingredients (API) market is projected to flourish at a CAGR...
New demonstration of the predictive power of an in silico clinical trial in oncology
November 13, 2023 02:00 ET
|
Novadiscovery
New demonstration of the predictive power of an in silico clinical trial in oncology Quantitative Systems Pharmacology (QSP) model of lung cancer and 5,900 digital patients architected to complete...
Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting
November 13, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE - 13 November 2023, 07:00 CET Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting Mechelen, Belgium and Itasca (IL),...